GlobeNewswire PharmaOriginal article
Press Release: Q2 2026: double-digit sales growth and strong business EPS growth; 2026 guidance upgraded
EarningsPositive
AI Analysis
Summary
A company reported double-digit sales growth and strong EPS growth in Q2 2026, with upgraded full-year 2026 guidance.
Financial Highlights
Revenue
double-digit growth
EPS
strong business EPS growth
Guidance
2026 guidance upgraded
Importance:5/10
Sentiment:
0.70
Q2 earningsguidance upgraderevenue growthEPS growth
Read the original article
Published by GlobeNewswire Pharma on July 30, 2026 5:30 AM